Heparin Sodium in Dextrose (B. Braun Medical Inc.)


Welcome to the PulseAid listing for the Heparin Sodium in Dextrose drug offered from B. Braun Medical Inc.. This Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: B. Braun Medical Inc.
NON-PROPRIETARY NAME: Heparin Sodium and Dextrose
SUBSTANCE NAME: HEPARIN SODIUM; DEXTROSE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1992-07-20
END MARKETING DATE: 0000-00-00


Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHeparin Sodium in Dextrose from B. Braun Medical Inc.
LABELER NAME: B. Braun Medical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4000; 5([USP’U]/100mL; g/100mL)
START MARKETING DATE: 1992-07-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0264-9567_82bf7254-281f-47ac-ab1f-9b45e20584ba
PRODUCT NDC: 0264-9567
APPLICATION NUMBER: NDA019952

Other HEPARIN SODIUM; DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Heparin Sodium in Dextrose